Evolva Financial Statements From 2010 to 2025
| ELVAFDelisted Stock | USD 0.90 0.00 0.00% |
Check Evolva Holding financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolva Holding's main balance sheet or income statement drivers, such as , as well as many indicators such as . Evolva financial statements analysis is a perfect complement when working with Evolva Holding Valuation or Volatility modules.
Evolva |
Evolva Holding SA Company Current Valuation Analysis
Evolva Holding's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Evolva Holding Current Valuation | 96.17 M |
Most of Evolva Holding's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evolva Holding SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Evolva Holding SA has a Current Valuation of 96.17 M. This is 99.33% lower than that of the Healthcare sector and 97.93% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.42% higher than that of the company.
Evolva Holding SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evolva Holding's current stock value. Our valuation model uses many indicators to compare Evolva Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evolva Holding competition to find correlations between indicators driving Evolva Holding's intrinsic value. More Info.Evolva Holding SA is one of the top stocks in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evolva Holding's earnings, one of the primary drivers of an investment's value.About Evolva Holding Financial Statements
Evolva Holding stakeholders use historical fundamental indicators, such as Evolva Holding's revenue or net income, to determine how well the company is positioned to perform in the future. Although Evolva Holding investors may analyze each financial statement separately, they are all interrelated. For example, changes in Evolva Holding's assets and liabilities are reflected in the revenues and expenses on Evolva Holding's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Evolva Holding SA. Please read more on our technical analysis and fundamental analysis pages.
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. The company was founded in 2004 and is headquartered in Reinach, Switzerland. Evolva Holding operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 62 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Evolva Pink Sheet
If you are still planning to invest in Evolva Holding SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evolva Holding's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |